当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 资产负债表

华熙生物

(688363)

  

流通市值:116.47亿  总市值:283.08亿
流通股本:1.98亿   总股本:4.82亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,127,091,845.151,276,628,393.671,388,473,254.831,606,128,994.81
应收票据及应收账款520,716,033.49550,233,387.51487,182,186.7448,436,857.87
应收账款520,716,033.49550,233,387.51487,182,186.7448,436,857.87
应收款项融资9,920,723.55,500,775.796,800,607.289,433,765.07
预付款项199,260,874.97178,416,508.1215,232,704.18171,764,299.84
其他应收款合计40,715,609.6743,062,261.7148,038,144.6451,909,847.8
存货1,197,535,005.421,175,104,735.171,178,801,733.371,161,536,727.01
其他流动资产41,896,960.5315,149,388.6922,062,602.943,167,059.47
流动资产平衡项目0000
流动资产合计3,207,373,119.43,314,356,200.643,546,740,658.594,023,100,101.48
非流动资产:
长期股权投资144,427,164.48140,720,645.0867,295,481.6468,226,169.37
其他权益工具投资64,592,939.464,605,372.8530,000,00030,000,000
其他非流动金融资产32,135,783.4132,135,783.4132,135,783.4132,135,783.41
固定资产2,279,127,010.71,949,592,104.761,977,701,613.521,899,280,394.38
在建工程954,720,610.951,159,524,150.22943,055,783.57830,447,047.7
使用权资产84,677,245.0184,678,105.9687,517,406.898,703,628.89
无形资产486,822,818.94487,704,327.67470,981,075.73475,063,369.18
商誉248,725,648.09251,443,433.95247,884,827.27247,218,867.42
长期待摊费用104,714,640.36109,449,933.77113,472,670.82116,432,616.52
递延所得税资产362,368,659.54331,800,314.38323,442,103.72302,589,095.9
其他非流动资产379,877,895.71442,311,810.69619,342,388.65558,557,276.32
非流动资产平衡项目0000
非流动资产合计5,142,190,416.595,053,965,982.744,912,829,135.134,658,654,249.09
资产平衡项目0000
资产总计8,349,563,535.998,368,322,183.388,459,569,793.728,681,754,350.57
流动负债:
短期借款--139,743,793.72139,195,740.46
应付票据及应付账款583,217,877.12650,990,219.75608,648,472.3848,338,977.96
其中:应付票据10,831,00029,958,00057,267,00031,500,000
应付账款572,386,877.12621,032,219.75551,381,472.3816,838,977.96
合同负债68,360,834.9974,687,975.1284,491,008.6167,741,209.71
应付职工薪酬116,641,000.6126,975,187.48103,005,432.52311,533,052.19
应交税费158,329,088.36158,938,935.2981,741,668.19109,506,248.1
其他应付款合计43,023,470.8848,295,156.3595,947,699.5469,681,216.97
一年内到期的非流动负债134,637,697.17147,163,971.36159,751,634.990,203,608.31
其他流动负债5,366,638.28,560,894.219,366,072.587,838,529.36
流动负债平衡项目00-0.010
流动负债合计1,109,576,607.321,215,612,339.561,282,695,782.351,644,038,583.06
非流动负债:
长期借款2,614,148.453,107,582.043,329,786.11107,966,763.25
租赁负债61,549,429.6646,221,379.5838,250,559.0752,423,028.77
递延收益196,955,551.3189,957,773.19190,524,707.06188,681,863.65
递延所得税负债4,686,185.285,008,321.195,332,097.315,656,033.59
非流动负债平衡项目0000
非流动负债合计265,805,314.69244,295,056237,437,149.55354,727,689.26
负债平衡项目0000
负债合计1,375,381,922.011,459,907,395.561,520,132,931.91,998,766,272.32
所有者权益(或股东权益):
实收资本(或股本)481,678,242481,678,242481,524,252481,085,277
资本公积3,830,942,255.653,823,586,509.023,802,474,925.23,752,826,726.75
减:库存股8,388,185.94---
其他综合收益-1,306,241.6411,238,644.16-9,707,841.88-9,097,538.43
盈余公积253,808,683.26253,808,683.26253,808,683.26253,808,683.26
未分配利润2,369,552,658.352,285,937,399.732,355,637,836.842,155,152,431.75
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计6,926,287,411.686,856,249,478.176,883,737,855.426,633,775,580.33
少数股东权益47,894,202.352,165,309.6555,699,006.449,212,497.92
股东权益平衡项目0000
股东权益合计6,974,181,613.986,908,414,787.826,939,436,861.826,682,988,078.25
负债和股东权益合计8,349,563,535.998,368,322,183.388,459,569,793.728,681,754,350.57
公告日期2023-10-312023-08-302023-04-292023-03-31
审计意见(境内)标准无保留意见
TOP↑